Related Experiment Video
Updated: Feb 7, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary artery
Byung Jin Kim1, Yun Seok Kim2, Ho Jin Kim3
1Medical Sciences Division, University of Oxford, Oxford, UK.
Insights
Adding mitral valve surgery to coronary artery bypass grafting for moderate ischemic mitral regurgitation increases early risks. Long-term benefits are not significant, suggesting CABG alone may be preferable for these patients.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Mitral Valve Disease
Background:
- The clinical benefit of concurrent mitral valve (MV) surgery with coronary artery bypass grafting (CABG) for moderate ischemic mitral regurgitation (iMR) is debated.
- Understanding the risks and benefits is crucial for patient management.
Purpose of the Study:
- To evaluate the impact of concomitant MV surgery on outcomes in patients with moderate iMR undergoing CABG.
- To compare early and long-term clinical and echocardiographic results between CABG-only and CABG with MV surgery.
Main Methods:
- A cohort of 710 patients with moderate iMR undergoing CABG (1990-2015) was analyzed.
- 116 patients (16.3%) had concomitant MV surgery (MVS), while 594 (83.7%) had CABG only.
- Propensity score matching was used to adjust for baseline differences and compare outcomes.
Main Results:
- Concomitant MV surgery was associated with increased early mortality, low cardiac output syndrome, and surgical bleeding.
- After adjustment, the risk of early death remained significantly higher in the MVS group.
- Long-term survival showed a trend towards increased mortality with MVS, but this difference diminished at 1 year post-surgery.
- Both groups showed similar improvements in left ventricular ejection fraction and reverse remodeling.
Conclusions:
- Concomitant MV surgery in moderate iMR patients undergoing CABG increases early mortality and complication risks.
- No significant long-term clinical or echocardiographic benefits were observed with the addition of MV surgery.
- CABG alone may be a safer option for selected patients with moderate iMR.
Background:
The clinical benefits of a concomitant mitral valve (MV) surgery in patients with moderate ischemic mitral regurgitation (iMR) undergoing coronary artery bypass grafting (CABG) remain controversial.
Methods:
The study involved 710 patients (mean age, 65.0±8.9 years; 504 males) with moderate iMR undergoing CABG between 1990 and 2015. Of these, 116 (16.3%) patients underwent a concomitant MV surgery (MVS; replacement in 10, repair in 106) and 594 (83.7%) underwent CABG only. Clinical and echocardiographic outcomes were compared before and after adjustment with the use of propensity score (PS) analyses.
Results:
Early mortality occurred in 22 (3.7%) and 13 (11.2%) patients in CABG-only and CABG with MVS group, respectively (P=0.001). After adjustment, CABG with MVS group showed significantly increased risks of early death (P<0.001), low cardiac output syndrome (LCOS) (P=0.001) and surgical bleeding (P=0.014). During a median follow-up of 78.0 months (quartile 1-3, 33.6-115.9 months), overall mortality occurred in 286 (40.3%) patients. The addition of an MV surgery showed an increased risk of overall mortality [hazard ratio (HR), 1.34; 95% confidence interval (CI), 0.99-1.80; P=0.055], which became comparable 1 year after surgery on landmark survival analysis (HR, 0.94; 95% CI, 0.64-1.39; P=0.772). Improved left ventricular (LV) ejection fraction and LV reverse remodeling were observed in both groups without significant intergroup differences.
Conclusions:
The addition of a concomitant MV surgery increased the risk of early mortality and complications in patients with moderate iMR undergoing CABG. In long-term clinical and echocardiographic outcomes, a concomitant MV surgery seemed to confer no significant clinical benefits.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

